Key result
Each 10-year increase in vascular age gap is linked to ~14% higher retinopathy risk in T1D.
Why the study?
Early vascular aging based on vascular age gap reflects excess vascular aging beyond chronological age, but its clinical relevance in type 1 diabetes remains unclear.
Does early vascular aging based on carotid intima-media thickness associate with microvascular complications in adults with type 1 diabetes?
Cross-Sectional (n=569)
Does early vascular aging based on carotid intima-media thickness associate with microvascular complications in adults with type 1 diabetes?
Early vascular aging assessed by carotid intima-media thickness is highly prevalent in adults with type 1 diabetes and independently associates with microvascular complications.
Answers are grounded in this paper and cite their sources.
Vascular age gap may aid microvascular risk stratification in type 1 diabetes; leaves open causal inference and prospective validation.
Introduction and Objective: Early vascular aging (EVA), based on vascular age gap (VAG), reflects excess vascular aging beyond chronological age, but its clinical relevance in type 1 diabetes (T1D) remains unclear. We aimed to characterize EVA based on carotid intima-media thickness (cIMT) and its associations with microvascular complications in adults with T1D. Methods: This cross-sectional study included adults with T1D without clinical macrovascular disease or carotid plaque. Vascular age was derived from right common carotid artery cIMT using population-based reference equations; EVA was defined as VAG ≥5.7 years. Clinical data, laboratory parameters, skin autofluorescence, and diabetic complications were assessed. Multivariable linear and logistic regression models were applied. Results: We included 569 adults with T1D [median age 35 (28-43 years), diabetes duration 15 (10-25) years]. EVA affected 54.1% of participants. People with EVA had longer diabetes duration [16 (12-30) vs. 14 (9-20)years], more frequent hypertension (39.9 vs. 30.3%), and higher skin autofluorescence [2.30 (1.90-2.70) vs. 2.20 (1.80-2.50) AU], while HbA1c was similar. EVA was more prevalent among participants with retinopathy (49.4 vs. 31.4%) and nephropathy (22.4 vs. 10.3%). VAG increased by 3.3 years per 10 years of diabetes duration (p=0.001), 5.0 years in current smokers (p=0.01), and 3.8 years per 1-AU increase in skin autofluorescence (p=0.03). In logistic models adjusted for age, diabetes duration, blood pressure, body mass index, HbA1c, lipids, and smoking., a 10-year increase in VAG associated with any retinopathy (OR 1.14, 95% CI 1.02-1.27; p=0.025), proliferative retinopathy (OR 1.22, 95% CI 1.10-1.34; p=0.003), and nephropathy (OR 1.22, 95% CI 1.10-1.34; p=0.005). Conclusion: In adults with T1D without macroangiopathy, EVA assessed by cIMT is frequent and independently associates with diabetes duration, smoking, and advanced glycation, as well as with retinopathy and nephropathy. Disclosure M. Kulecki: None. D. Naskret: Speaker's Bureau; Ended; AstraZeneca, Novo Nordisk, Boehringer Ingelheim International GmbH, Bayer AG, Sanofi, Eli Lilly and Company. S. Pilacinski: None. A. Duda-Sobczak: None. A. Gandecka-Pempera: None. D. Zozulinska-Ziólkiewicz: Advisory Panel; Current; Abbott Diabetes. Speaker's Bureau; Current; Abbott Diabetes, Eli Lilly and Company, Novo Nordisk, Sanofi, Dexcom, Inc. Advisory Panel; Current; Medtronic. Speaker's Bureau; Current; Medtronic, Servier Laboratories.
No takes yet. Share an insight, caveat, or question.
KULECKI et al. (2026) conducted a cross-sectional in Type 1 diabetes (n=569). 10-year increase in vascular age gap (VAG) was evaluated on any retinopathy (OR 1.14, 95% CI 1.02-1.27, p=0.025). A 10-year increase in vascular age gap was associated with any retinopathy and nephropathy in adults with type 1 diabetes.
Synapse has enriched 10 related papers. Consider them for comparative context: